SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
21 WATERWAY AVENUE, SUITE 225 |
|
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc.
[ TELA ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
|
10% Owner |
|
Officer (give title below) |
X |
Other (specify below) |
See footnote 2 |
|
3. Date of Earliest Transaction
(Month/Day/Year) 01/13/2021
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock, par value $0.001 per share |
01/13/2021 |
|
P |
|
7,002 |
A |
$13.9
|
1,482,295 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/14/2021 |
|
P |
|
9,075 |
A |
$13.96
|
1,491,370 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/15/2021 |
|
P |
|
763 |
A |
$13.88
|
1,492,133 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/26/2021 |
|
P |
|
1,544 |
A |
$14.24
|
1,493,677 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/27/2021 |
|
P |
|
5,000 |
A |
$14.03
|
1,498,677 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/28/2021 |
|
P |
|
13,950 |
A |
$13.68
|
1,512,627 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
01/29/2021 |
|
P |
|
7,760 |
A |
$13.93
|
1,520,387 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
02/01/2021 |
|
P |
|
1,119 |
A |
$14.16
|
1,521,506 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
02/02/2021 |
|
P |
|
250 |
A |
$14.08
|
1,521,756 |
I |
See footnotes
|
Common Stock, par value $0.001 per share |
02/04/2021 |
|
P |
|
2,822 |
A |
$14.29
|
1,524,578 |
I |
See footnotes
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
1. Name and Address of Reporting Person*
21 WATERWAY AVENUE, SUITE 225 |
|
(Street)
|
1. Name and Address of Reporting Person*
21 WATERWAY AVENUE, SUITE 225 |
|
(Street)
|
1. Name and Address of Reporting Person*
21 WATERWAY AVENUE, SUITE 225 |
|
(Street)
|
1. Name and Address of Reporting Person*
21 WATERWAY AVENUE, SUITE 225 |
|
(Street)
|
Explanation of Responses: |
Remarks: |
|
EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter |
02/15/2021 |
|
EW HEALTHCARE PARTNERS FUND 2-A, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter |
02/15/2021 |
|
EW HEALTHCARE PARTNERS FUND 2 GP, L.P., By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter |
02/15/2021 |
|
EW HEALTHCARE PARTNERS FUND 2-UGP, LLC, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter |
02/15/2021 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
EXHIBIT 99.1 TO FORM 4
EW HEALTHCARE PARTNERS FUND 2, L.P.:
------------------------------------
Transaction Date Shares Acquired Shares Beneficially Owned
---------------- --------------- -------------------------
January 13, 2021 2,947 602,800
January 14, 2021 3,690 606,490
January 15, 2021 310 606,800
January 26, 2021 628 607,428
January 27. 2021 2,033 609,461
January 28, 2021 5,673 615,154
January 29, 2021 3,156 618,290
February 1, 2021 455 618,745
February 4, 2021 1,398 620,143
--------------- ----- --------
TOTAL 20,290 620,143
EW HEALTHCARE PARTNERS FUND 2-A, L.P.:
--------------------------------------
Transaction Date Shares Acquired Shares Beneficially Owned
---------------- --------------- -------------------------
January 13, 2021 4,055 879,495
January 14, 2021 5,385 884,880
January 15, 2021 453 885,333
January 26, 2021 916 886,249
January 27. 2021 2,967 889,216
January 28, 2021 8,277 897,493
January 29, 2021 4,604 902,097
February 1, 2021 664 902,761
February 2, 2021 250 903,011
February 4, 2021 1,424 904,435
--------------- ----- --------
TOTAL 28,995 904,435